Inarigivir soproxil - CAS 942123-43-5

Inarigivir soproxil (SB9200) is an agonist of innate immunity that demonstrates effective antiviral activity against resistant hepatitis C virus (HCV) variants, with EC50s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems.

HCV Protease, HBV

Microbiology/Virology, Proteases/Proteasome

942123-43-5

0.9844

C25H34N7O13PS

703.62

O(C)[C@H]1[C@@H](O[C@H](CO)[C@H]1OP(OC[C@H]2O[C@H](C[C@@H]2O)N3C=4C(N=C3)=C(N)N=CN4)(SCOC(OC(C)C)=O)=O)N5C(=O)NC(=O)C=C5

-20°C

Ice Packs

Small Compound